Have a personal or library account? Click to login
Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets Cover

Development and validation of HPLC and CE methods for simultaneous determination of amlodipine and atorvastatin in the presence of their acidic degradation products in tablets

Open Access
|Oct 2016

References

  1. 1. A. C. Moffat, M. D. Osselton and B. Widdop, Clarke’s Analysis of Drugs and Poisons, Pharmaceutical Press, London 2011.
  2. 2. L. L. Brunton, J. S. Lazo and K. L. Parker (Eds.), Goodman & Gilman’s The Pharmacological Basis of Therapeutics, 11th ed., McGraw-Hill, New York 2006.10.1345/aph.1G685
  3. 3. British Pharmacopoeia, Medicines and Healthcare Products Regulatory Agency (MHRA), London 2013.
  4. 4. United States Pharmacopeia, United States Pharmacopeial Convention, Rockville 2011.
  5. 5. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Sequential spectrophotometric method for the simultaneous determination of amlodipine, valsartan, and hydrochlorothiazide in coformulated tablets, Int. J. Spectrosc. 2013 (2013) article ID 273102; DOI: 10.1155/2013/273102.10.1155/2013/273102
  6. 6. D. Ramesh and M. Habibuddin, Stability indicating RP-HPLC method for the simultaneous determination of atorvastatin calcium, metformin hydrochloride, and glimepiride in bulk and combined tablet dosage form, Int. Schol. Res. Not. 2014 (2014) article ID 754695; DOI: 10.1155/2014/754695.10.1155/2014/754695489731527433531
  7. 7. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Different approaches in partial least squares and artificial neural network models applied for the analysis of a ternary mixture of amlodipine, valsartan and hydrochlorothiazide, Spectrochim. Acta A 122 (2014) 744-750; DOI: 10.1016/j.saa.2013.11.045.10.1016/j.saa.2013.11.04524378624
  8. 8. B. Ramesha, K. V. Reddy, B. Kishore, M. A. Kumar, L. Raju and B. Thara, Development and validation of a stability-indicating gradient RP-UHPLC method for the determination of impurities in atorvastatin drug substance, J. Liq. Chromatogr. Relat. Technol. 37 (2014) 275-297; DOI: 10.1080/10826076.2012.745135.10.1080/10826076.2012.745135
  9. 9. A. A. Elshanawane, L. M. Abdelaziz, M. M. Kamal and H. M. Hafez, Quantitative determination of telmisartan, ramipril, amlodipine besylate, and atorvastatin calcium by HPLC, J. Liq. Chromatogr. Relat. Technol. 37 (2014) 195-206; DOI: 10.1080/10826076.2012.738622.10.1080/10826076.2012.738622
  10. 10. E. S. Elzanfaly, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Continuous wavelet transform, a powerful alternative to derivative spectrophotometry in analysis of binary and ternary mixtures: A comparative study, Spectrochim. Acta A 151 (2015) 945-955; DOI: 10.1016/j.saa.2015.06.100.10.1016/j.saa.2015.06.10026186613
  11. 11. M. M. Bkhaitan and A. Z. Mirza, Stability‐indicating HPLC‐DAD method for simultaneous determination of atorvastatin, irbesartan, and amlodipine in bulk and pharmaceutical preparations, Bull. Korean Chem. Soc. 36 (2015) 2230-2237; DOI: 10.1002/bkcs.10433.10.1002/bkcs.10433
  12. 12. S. A. Hassan, E. S. Elzanfaly, M. Y. Salem and B. A. El-Zeany, Mean centering of double divisor ratio spectra, a novel spectrophotometric method for analysis of ternary mixtures, Spectrochim. Acta A 153 (2016) 132-142; DOI: 10.1016/j.saa.2015.07.109.10.1016/j.saa.2015.07.10926298680
  13. 13. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeiny, Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of amlodipine and atorvastatin, Spectrochim. Acta A 83 (2011) 140-148; DOI: 10.1016/j.saa.2011.08.005.10.1016/j.saa.2011.08.00521908232
  14. 14. Y. Zhou, J. Li, X. He, M. Jia, M. Liu, H. Li, Z. Xiong, Y. Fan and W. Li, Development and validation of a liquid chromatography-tandem mass spectrometry method for simultaneous determination of amlodipine, atorvastatin and its metabolites ortho-hydroxy atorvastatin and para-hydroxy atorvastatin in human plasma and its application in a bioequivalence study, J. Pharm. Biomed. Anal. 83 (2013) 101-107; DOI: 10.1016/j.jpba.2013.04.021.10.1016/j.jpba.2013.04.02123711572
  15. 15. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Development and validation of Hpoint standard addition method applied for the analysis of binary mixture of amlodipine and atorvastatin, Int. J. Pharm. Bio Sci. 4 (2013) 230-243.
  16. 16. A. Mohammadi, A. B. Moghaddam, K. Eilkhanizadeh, E. Alikhani, S. Mozaffari and T. Yavari, Electro-oxidation and simultaneous determination of amlodipine and atorvastatin in commercial tablets using carbon nanotube modified electrode, Micro Nano Lett. 8 (2013) 413-417; DOI: 10.1049/ mnl.2013.0080.10.1049/mnl.2013.0080
  17. 17. B. A. Moussa, A. A. El-Zaher, M. A. Mahrouse and M. S. Ahmed, Simultaneous determination of amlodipine besylate and atorvastatin calcium in binary mixture by spectrofluorimetry and HPLC coupled with fluorescence detection, Anal. Chem. Insights 8 (2013) 107-115; DOI: 10.4137/ACI.S12921.10.4137/ACI.S12921382565024250220
  18. 18. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Three different methods for determination of binary mixture of amlodipine and atorvastatin using dual wavelength spectrophotometry, Spectrochim. Acta A 104 (2013) 70-76; DOI: 10.1016/j.saa.2012.11.079.10.1016/j.saa.2012.11.07923266678
  19. 19. P. Haritha, B. S. Rao and Y. Sunandamma, Method development and validation for simultaneous determination of amlodipine besylate and atorvastatin calcium by RP-HPLC technique, Asian J. Res. Chem. 7 (2014) 438-445.
  20. 20. N . Ibrahim, M. Rizk, A. Ibrahim, S. Tawakkol and I. Ali, Simultaneous determination of amlodipine besylate and atorvastatin calcium by using spectrophotometric method with multivariate calibration and HPLC method implementing „design of experiment”, Int. J. Pharm. Pharm. Sci. 6 (2014) 419-425.
  21. 21. A. L. Vonica-Gligor, T. Casian, A. Reznek, I. Tomuta and F. Gligor, Simultaneous quantification of atorvastatin and amlodipine in powder blends for tableting by NIR spectroscopy and chemometry, Farmacia 63 (2015) 381-387.
  22. 22. B. G. Chaudhari, N. M. Patel and P. B. Shah, Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products, Chem. Pharm. Bull. (Tokyo) 55 (2007) 241-246; DOI: 10.1248/cpb.55.241.10.1248/cpb.55.24117268096
  23. 23. A. Mohammadi, N. Rezanour, M. Ansari Dogaheh, F. Ghorbani Bidkorbeh, M. Hashem and R. Walker, A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets, J. Chromatogr. B 846 (2007) 215-221; DOI: 10.1016/j.jchromb.2006.09.007.10.1016/j.jchromb.2006.09.00717010681
  24. 24. D. Shah, K. Bhatt, R. Mehta, S. Baldania and T. Gandhi, Stability indicating RP-HPLC estimation of atorvastatin calcium and amlodipine besylate in pharmaceutical formulations, Indian J. Pharm. Sci. 70 (2008) 754-760; DOI: 10.4103/0250-474X.49117.10.4103/0250-474X.49117304086921369436
  25. 25. M. Hefnawy, M. Sultan and H. Al-Johar, Development of capillary electrophoresis technique for simultaneous measurement of amlodipine and atorvastatin from their combination drug formulations, J. Liq. Chromatogr. Relat. Technol. 32 (2009) 2923-2942; DOI: 10.1080/10826070903320681.10.1080/10826070903320681
  26. 26. H. W. Darwish, S. A. Hassan, M. Y. Salem and B. A. El-Zeany, Advanced stability indicating chemometric methods for quantitation of amlodipine and atorvastatin in their quinary mixture with acidic degradation products, Spectrochim. Acta A 154 (2016) 58-66; DOI: 10.1016/j.saa.2015.10.007.10.1016/j.saa.2015.10.00726513228
  27. 27. A. A. Shirkhedkar and S. J. Surana, Simultaneous densitometric TLC analysis of atorvastatin calcium and fenofibrate in the bulk drug and in pharmaceutical formulations, J. Planar Chromatogr.- Mod. TLC 22 (2009) 355-358; DOI: 10.1556/JPC.22.2009.5.7.10.1556/JPC.22.2009.5.7
  28. 28. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline. Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH, Nov 2005.
DOI: https://doi.org/10.1515/acph-2016-0040 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 479 - 490
Accepted on: May 1, 2016
Published on: Oct 15, 2016
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2016 Said A. Hassan, Eman S. Elzanfaly, Salem Badr A. El-Zeany, Maissa Y. Salem, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.